2m 2m 2m 2m 2m 2m 2m
BeOne Medi Sp ADR (ONC)
NASDAQ
$276.00+$4.19 (+1.54%)
Price as of Jun 23, 2026 4:22 PM EDT- $25.8BMarket Cap
- 5.55%1-Year Change
- BiotechnologyIndustry
BeOne Medi Sp ADR (ONC)
$276.00+$4.19 (+1.54%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 5.3B +38.63% | 3.8B +7,678.86% | 49.0M -96.54% | 1.4B +9,085.98% | |
Cost of Revenue | 668.5M +12.53% | 594.1M +56.37% | 379.9M +32.62% | 286.5M +73.72% | |
Gross Profit | 4.7B +45.34% | 3.2B +54.71% | 2.1B +84.06% | 1.1B +725.17% | |
Sales and Marketing Expense | 2.1B +13.68% | 1.8B +501.25% | 304.5M -76.17% | 1.3B +29.06% | |
Research and Development Expense | -2.1B +9.86% | -2.0B +498.14% | -326.6M -80.09% | -1.6B +12.42% | |
Depreciation and Amortization Expense | 141.7M -17.51% | 171.8M +95.91% | 87.7M +32.28% | 66.3M +42.67% | |
Total Operating Expenses | 4.2B +11.71% | 3.8B +499.64% | 631.1M -80.31% | 3.2B +22.58% | |
Operating Profit | 447.1M +178.69% | -568.2M -9.97% | -631.1M -64.74% | -1.8B +24.39% | |
Interest Income | 70.5M N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | -20.9M -55.46% | -46.9M +125.45% | -20.8M -4.14% | -21.7M +37.71% | |
Interest Income and Expense and Net | 49.6M +205.81% | -46.9M +125.45% | -20.8M -4.14% | -21.7M +37.71% | |
Total Nonoperating Income and Expense | -42.6M +236.71% | -12.6M -95.76% | -297.9M +33.06% | -223.9M -1,507.52% | |
Income before Taxes | 416.9M +178.21% | -533.0M -39.55% | -881.7M -55.04% | -2.0B +36.32% | |
Income Taxes | 129.9M +16.22% | 111.8M +6,357.83% | 1.7M -95.95% | 42.8M +269.53% | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 286.9M +144.50% | -644.8M -26.87% | -881.7M -56.00% | -2.0B +41.78% | |
Net Income from Continuing Operations Applicable to Common | 416.9M +178.21% | -533.0M -39.55% | -881.7M -56.00% | -2.0B +41.78% | |
Basic EPS and Net Income | 0.20 +142.55% | -0.47 -27.69% | -0.65 -56.38% | -1.49 +27.35% | |
Diluted EPS and Net Income | 0.19 +140.43% | -0.47 -27.69% | -0.65 -56.38% | -1.49 +27.35% | |
Basic Weighted Average Shares | 1.4B +3.58% | 1.4B +0.86% | 1.4B +1.22% | 1.3B +11.15% | |
Diluted Weighted Average Shares | 1.5B +7.75% | 1.4B +0.86% | 1.4B +1.22% | 1.3B +11.15% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 4.5B +73.08% | 2.6B +262.92% | 724.0M -81.29% | 3.9B -11.57% | |
Short-Term Investments | N/A N/A | 2.6M 0.00% | 2.6M -99.61% | 665.3M -70.33% | |
Cash and Cash Equivalents and Short-Term Investments | 4.5B +72.91% | 2.6B +261.98% | 726.6M -83.98% | 4.5B -31.47% | |
Total Current Assets | 6.2B +56.17% | 4.0B +164.44% | 1.5B -71.01% | 5.2B -31.61% | |
Accumulated Depreciation | 528.7M +32.47% | 399.1M +60.15% | 249.2M +45.34% | 171.5M +37.96% | |
Property and Plant and Equipment and Net | 1.6B +4.01% | 1.6B +30.73% | 1.2B +42.72% | 845.9M +43.97% | |
Total Long-Term Assets | 2.0B +1.33% | 1.9B +2,681.56% | 69.4M -94.08% | 1.2B +13.58% | |
Total Assets | 8.2B +38.30% | 5.9B +22.93% | 4.8B -24.50% | 6.4B -26.22% | |
Income Taxes Payable | 94.8M +39.59% | 67.9M +72.23% | 39.4M -4.22% | 41.2M +15.81% | |
Total Short-Term Debt | 57.3M -93.27% | 851.5M -90.95% | 9.4B +2,760.33% | 329.0M -23.06% | |
Total Current Liabilities | 1.8B -17.43% | 2.2B +100.01% | 1.1B -24.59% | 1.5B -8.19% | |
Total Long-Term Debt | 961.9M +477.78% | 166.5M -15.75% | 197.6M -5.51% | 209.1M +3.48% | |
Total Long-Term Liabilities | 2.0B +434.67% | 373.8M +117.76% | 171.6M -67.45% | 527.4M -34.35% | |
Total Liabilities | 3.8B +47.85% | 2.6B +102.39% | 1.3B -35.92% | 2.0B -16.94% | |
Retained Earnings | -8.3B -3.33% | -8.6B +8.10% | -8.0B +12.45% | -7.1B +42.57% | |
Total Stockholders Equity | 4.4B +30.88% | 3.3B -5.80% | 3.5B -19.30% | 4.4B -29.79% | |
Total Shares Outstanding | 1.4B +3.87% | 1.4B +2.05% | 1.4B +0.25% | 1.4B +1.60% | |
Cash Flow | |||||
Cash from Operating Activities | 1.1B +901.80% | -140.6M -87.97% | -1.2B -21.92% | -1.5B +15.24% | |
Capital Expenditures | 185.8M -62.28% | 492.7M -12.32% | 561.9M +72.66% | 325.4M +23.77% | |
Cash from Investing Activities | -276.2M -49.64% | -548.4M +243.26% | -159.7M -114.83% | 1.1B +68.13% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 1.1B +447.66% | 193.4M -37.71% | 310.6M +1,736.98% | -19.0M -100.52% | |
Financials Ratio | |||||
Gross Margin | 87.34% +3.48% | 84.41% +112.49% | -675.63% -947.00% | 79.77% -93.04% | |
Operating Margin | 8.47% +156.77% | -14.91% -98.84% | -1,288.44% +919.37% | -126.40% -101.38% | |
Return on Assets | 4.07% +133.86% | -12.01% -23.75% | -15.75% -40.95% | -26.67% +34.43% | |
Return on Equity | 7.46% +139.74% | -18.77% -15.68% | -22.26% -40.97% | -37.71% +34.92% | |
Revenue Growth | 38.63% -99.50% | 7,678.86% +8,054.02% | -96.54% -101.06% | 9,085.98% +8,744.97% | |
Current Ratio | 3.41 +89.13% | 1.80 +32.22% | 1.36 -61.56% | 3.55 -25.51% | |
Cash Ratio | 2.49 +109.63% | 1.19 +81.46% | 0.65 -75.19% | 2.64 -3.68% | |
Debt-to-Equity Ratio | 0.23 -23.50% | 0.31 -88.75% | 2.72 +2,111.73% | 0.12 +21.70% | |
Debt-to-Assets Ratio | 0.12 -27.57% | 0.17 -91.38% | 1.99 +2,263.39% | 0.08 +15.93% | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow